Want to see SE:BICO full AI Analyst Report?
BICO Stock Chart & Stats
kr13.38
kr0.92(6.88%)
At close: 4:00 PM EDT
kr13.38
kr0.92(6.88%)
Day’s Range― - ―
52-Week Rangekr12.94 - kr28.30
Previous CloseN/A
Volume297.54K
Average Volume (3M)288.59K
Market Cap
kr1.15B
Enterprise Valuekr1.12K
Total Cash (Recent Filing)kr744.30M
Total Debt (Recent Filing)kr690.60M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.97
Shares Outstanding69,074,900
10 Day Avg. Volume264,488
30 Day Avg. Volume288,586
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.85
Price to Sales (P/S)0.99
P/FCF Ratio26.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.7
Revenue Forecast (FY)kr1.55B
Bulls Say, Bears Say
Bulls Say
Margin Expansion And Cost EfficiencyThe sharp improvement in gross margin, adjusted EBITDA and operating expenses indicates progress toward a more scalable operating model. The Lyon-to-Berlin consolidation and efficiency program could support lasting margin gains if execution remains disciplined.
Recurring Consumables And Product InnovationGrowth in consumables strengthens the recurring revenue base attached to BICO’s installed instruments. New software and automation products can deepen customer workflows, improve retention and support cross-selling across research and biopharma accounts.
Long-Term Contracting And Balance SheetThe multiyear Scienion agreement provides meaningful contracted visibility, while the move to net cash improves resilience. Stronger liquidity gives BICO more capacity to fund development, absorb volatility and pursue selective growth opportunities.
Bears Say
Deep And Volatile LossesBICO has not yet converted improved gross margins into sustainable earnings. Deep and volatile losses can erode equity, limit strategic flexibility and increase reliance on successful restructuring, commercialization and continued balance-sheet discipline.
Project Execution And Revenue VisibilityExecution problems in complex project-based automation can delay revenue, consume management resources and weaken customer confidence. Lumpy delivery patterns make forecasting harder and could offset improvements from more standardized products and workflows.
Cash Flow And End-Market PressureNegative operating cash flow despite reported operational improvement highlights working-capital and conversion risk. Weak academic demand, longer sales cycles and delayed automation spending could constrain growth and keep cash generation uneven.
BICO Group AB Class B News
BICO FAQ
What was BICO Group AB Class B’s price range in the past 12 months?
BICO Group AB Class B lowest stock price was kr12.94 and its highest was kr28.30 in the past 12 months.
What is BICO Group AB Class B’s market cap?
BICO Group AB Class B’s market cap is kr1.15B.
When is BICO Group AB Class B’s upcoming earnings report date?
BICO Group AB Class B’s upcoming earnings report date is Nov 11, 2026 which is in 83 days.
How were BICO Group AB Class B’s earnings last quarter?
BICO Group AB Class B released its earnings results on Aug 19, 2026. The company reported -kr0.527 earnings per share for the quarter, missing the consensus estimate of -kr0.5 by -kr0.027.
Is BICO Group AB Class B overvalued?
According to Wall Street analysts BICO Group AB Class B’s price is currently Overvalued.
Does BICO Group AB Class B pay dividends?
BICO Group AB Class B does not currently pay dividends.
What is BICO Group AB Class B’s EPS estimate?
BICO Group AB Class B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BICO Group AB Class B have?
BICO Group AB Class B has 69,074,900 shares outstanding.
What happened to BICO Group AB Class B’s price movement after its last earnings report?
BICO Group AB Class B reported an EPS of -kr0.527 in its last earnings report, missing expectations of -kr0.5. Following the earnings report the stock price went up 9.989%.
Which hedge fund is a major shareholder of BICO Group AB Class B?
Currently, no hedge funds are holding shares in SE:BICO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BICO Group AB Class B
BICO Group AB (publ) is a global bio-convergence enterprise, extending its operations across North America, Europe, Asia, and other international markets. Its business is segmented into two primary divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions division equips researchers with advanced tools like 3D bioprinters, hybrid microscopes, and instruments for single-cell dispensing and liquid handling. It also supplies essential consumables such as bioinks, reagents, microscope lenses, and specialized software, alongside 3D reconstructed human tissues crucial for regulatory testing. Furthermore, this segment provides specialized services in 3D cell culture, tissue imaging, multiplex imaging, and digital pathology, primarily benefiting pharmaceutical and biotechnology firms. Conversely, the Bioautomation segment caters to industrial clients with precision dispensing and biosensor technologies, while also delivering diagnostic automation and sophisticated robotics solutions to the medical and diagnostics sectors. Beyond these segments, BICO Group's comprehensive portfolio includes solutions for tissue engineering, multi-omics, cell line development, and diagnostics, contributing to a robust industrial ecosystem. Its principal clientele spans the medical, pharmaceutical, and cosmetic industries. Originally established in 2016 as Cellink AB (publ), the company adopted its current name, BICO Group AB (publ), in August 2021. Its headquarters are located in Gothenburg, Sweden.
BICO Company Deck
BICO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call combined meaningful operational and financial improvements (strong product launches, a large long-term license/supply agreement, substantial gross margin expansion, improved adjusted EBITDA margin, reductions in operating expenses and a stronger balance sheet) with persistent operational and market headwinds (project execution issues in the U.S. project business, negative operating cash flow driven by working capital movements, soft North American/academic end markets and longer sales cycles for large automation projects). Progress on commercialization and profitability is clear, but execution risk in project-based automation and short-term cash-flow/working-capital pressure leave mixed near-term visibility.View all SE:BICO earnings summariesTechnical Analysis
Vitrolife AB
―
BONESUPPORT HOLDING AB
―
CellaVision AB
―
Xvivo Perfusion AB
―
OssDsign AB
―